These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34854264)

  • 1. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
    Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
    J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
    BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
    Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
    BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
    J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PK-PD Integration Modeling and Cutoff Value of Florfenicol against
    Lei Z; Liu Q; Yang S; Yang B; Khaliq H; Li K; Ahmed S; Sajid A; Zhang B; Chen P; Qiu Y; Cao J; He Q
    Front Pharmacol; 2018; 9():2. PubMed ID: 29387013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
    Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
    BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against
    Somogyi Z; Mag P; Kovács D; Kerek Á; Szabó P; Makrai L; Jerzsele Á
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
    Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
    J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against
    Huang A; Mao F; Huang L; Xie S; Pan Y; Qu W; Cheng G; Liu Z; Yuan Z; Peng D; Hao H
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203885
    [No Abstract]   [Full Text] [Related]  

  • 11. PK-PD Analysis of Marbofloxacin against
    Lei Z; Liu Q; Yang B; Khaliq H; Cao J; He Q
    Front Pharmacol; 2017; 8():856. PubMed ID: 29209222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals.
    Lee DH; Birhanu BT; Lee EB; Lee SJ; Boby N; Park YS; Park SC
    Vet Res; 2020 Oct; 51(1):131. PubMed ID: 33059768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an experimental PRRSV and Streptococcus suis coinfection on the pharmacokinetics of ceftiofur hydrochloride after intramuscular injection in pigs.
    Day DN; Sparks JW; Karriker LA; Stalder KJ; Wulf LW; Zhang J; Kinyon JM; Stock ML; Gehring R; Wang C; Ellingson J; Coetzee JF
    J Vet Pharmacol Ther; 2015 Oct; 38(5):475-81. PubMed ID: 25689130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics.
    Lebel G; Piché F; Frenette M; Gottschalk M; Grenier D
    Peptides; 2013 Dec; 50():19-23. PubMed ID: 24096107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.
    Wang J; Hao H; Huang L; Liu Z; Chen D; Yuan Z
    Front Microbiol; 2016; 7():36. PubMed ID: 26870006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and Validation of Dosage Regimen for Ceftiofur against
    Mi K; Pu S; Hou Y; Sun L; Zhou K; Ma W; Xu X; Huo M; Liu Z; Xie C; Qu W; Huang L
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for
    Zhou YF; Peng HM; Bu MX; Liu YH; Sun J; Liao XP
    Front Pharmacol; 2017; 8():684. PubMed ID: 29033841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
    Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z
    J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Mi K; Ahmad I; Xie S; Hussain HI; Yuan Z; Dai M; Huang L
    Microb Pathog; 2020 Apr; 141():103981. PubMed ID: 31962185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.